0001213900-18-011211.txt : 20180815 0001213900-18-011211.hdr.sgml : 20180815 20180815170613 ACCESSION NUMBER: 0001213900-18-011211 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180813 FILED AS OF DATE: 20180815 DATE AS OF CHANGE: 20180815 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOLUBIAK MYRON Z CENTRAL INDEX KEY: 0001199080 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38174 FILM NUMBER: 181021654 MAIL ADDRESS: STREET 1: C/O CITIUS PHARMACEUTICALS, INC. STREET 2: 63 GREAT ROAD CITY: MAYNARD STATE: MA ZIP: 01754 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Citius Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001506251 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 273425913 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 BUSINESS PHONE: (908) 967-6676 MAIL ADDRESS: STREET 1: 11 COMMERCE DRIVE STREET 2: 1ST FLOOR CITY: CRANFORD STATE: NJ ZIP: 07016 FORMER COMPANY: FORMER CONFORMED NAME: Trail One, Inc. DATE OF NAME CHANGE: 20110314 FORMER COMPANY: FORMER CONFORMED NAME: TrailOne, Inc. DATE OF NAME CHANGE: 20101119 4 1 ownership.xml X0306 4 2018-08-13 0 0001506251 Citius Pharmaceuticals, Inc. CTXR 0001199080 HOLUBIAK MYRON Z C/O CITIUS PHARMACEUTICALS, INC. 11 COMMERCE DRIVE, 1ST FLOOR CRANFORD NJ 07016 1 1 1 0 President and CEO Common Stock 2018-08-13 4 P 0 784314 1.275 A 1304196 D Warrant to Purchase Common Stock 1.15 2018-08-13 4 A 0 784314 A 2023-08-14 Common Stock 784314 784314 D Options to Purchase Common Stock 8.10 2025-10-01 Common Stock 26667 26667 D Options to Purchase Common Stock 3.45 2027-09-13 Common Stock 40000 40000 D Warrant to Purchase Common Stock 6.21 2019-06-12 Common Stock 19615 19615 D The warrant is fully vested and exercisable immediately. The purchase price of the warrants was included in the purchase price of the common stock reported in Table I. The option granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015. One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest. /s/ Alexander M. Donaldson, by power of attorney 2018-08-15